Antimicrobial Resistance (AMR) in Italy over the Past Five Years: A Systematic Review

M. Montalti, G. Soldà, Angelo Capodici, Z. Di Valerio, G. Gribaudo, Giusy La Fauci, A. Salussolia, Francesca Scognamiglio, A. Zannoner, D. Gori
{"title":"Antimicrobial Resistance (AMR) in Italy over the Past Five Years: A Systematic Review","authors":"M. Montalti, G. Soldà, Angelo Capodici, Z. Di Valerio, G. Gribaudo, Giusy La Fauci, A. Salussolia, Francesca Scognamiglio, A. Zannoner, D. Gori","doi":"10.3390/biologics2020012","DOIUrl":null,"url":null,"abstract":"Antimicrobial Resistance (AMR) has become a global threat to public health systems around the world in recent decades. In 2017, Italy was placed among the worst-performing nations in Europe by the European Centre for Disease Prevention and Control, due to worryingly high levels of AMR in Italian hospitals and regions. The aim of this systematic review was to investigate the state of the art of research on AMR in Italy over the last five years. The PubMed database was searched to identify studies presenting original data. Forty-three of the 9721 records identified were included. Overall, AMR rates ranged from 3% (in a group of sheep farmers) to 78% (in a hospital setting). The methods used to identify the microorganisms, to test their susceptibility and the criteria adopted for the breakpoint were deficient in 7, 7 and 11 studies, respectively. The main findings of our review were that most studies (79.1%) considered hospitalised patients only, 4 studies (9.3%) analysed non-hospitalised populations only. In addition, only 7 studies were multicentric and no scientific literature on the subject was produced in 7 Italian regions. In order to have a solid basis on the topic for the interventions of public health professionals and other stakeholders, studies analysing the phenomenon should be conducted in a methodologically standardised manner, should include all areas of the country and should also focus on out-of-hospital and community-based care and work settings.","PeriodicalId":93526,"journal":{"name":"Biologics (Basel, Switzerland)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biologics (Basel, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/biologics2020012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Antimicrobial Resistance (AMR) has become a global threat to public health systems around the world in recent decades. In 2017, Italy was placed among the worst-performing nations in Europe by the European Centre for Disease Prevention and Control, due to worryingly high levels of AMR in Italian hospitals and regions. The aim of this systematic review was to investigate the state of the art of research on AMR in Italy over the last five years. The PubMed database was searched to identify studies presenting original data. Forty-three of the 9721 records identified were included. Overall, AMR rates ranged from 3% (in a group of sheep farmers) to 78% (in a hospital setting). The methods used to identify the microorganisms, to test their susceptibility and the criteria adopted for the breakpoint were deficient in 7, 7 and 11 studies, respectively. The main findings of our review were that most studies (79.1%) considered hospitalised patients only, 4 studies (9.3%) analysed non-hospitalised populations only. In addition, only 7 studies were multicentric and no scientific literature on the subject was produced in 7 Italian regions. In order to have a solid basis on the topic for the interventions of public health professionals and other stakeholders, studies analysing the phenomenon should be conducted in a methodologically standardised manner, should include all areas of the country and should also focus on out-of-hospital and community-based care and work settings.
意大利过去五年的抗微生物耐药性(AMR):系统综述
近几十年来,抗微生物耐药性(AMR)已成为全球公共卫生系统的威胁。2017年,由于意大利医院和地区的AMR水平高得令人担忧,意大利被欧洲疾病预防和控制中心列为欧洲表现最差的国家之一。本系统综述的目的是调查过去五年来意大利AMR的研究现状。检索PubMed数据库以确定提供原始数据的研究。在已确定的9721份记录中,有43份被包括在内。总体而言,AMR发病率从3%(在一群养羊人中)到78%(在医院环境中)不等。用于鉴定微生物、测试其易感性的方法和断点采用的标准分别在7项、7项和11项研究中存在缺陷。我们综述的主要发现是,大多数研究(79.1%)仅考虑住院患者,4项研究(9.3%)仅分析非住院人群。此外,只有7项研究是多中心的,意大利7个地区没有关于该主题的科学文献。为了为公共卫生专业人员和其他利益相关者的干预奠定坚实的基础,分析这一现象的研究应以方法标准化的方式进行,应包括全国所有地区,还应侧重于院外和社区护理和工作环境。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信